The Cytel blog keeps you up to speed with the latest developments in biostatistics and clinical biometrics.

Opening the Black Box: Moving to Explainable AI

May 7, 2019

 

 
Nowadays, it’s difficult to pick up a mainstream newspaper or read an industry publication without seeing reference to Artificial Intelligence or AI and progress towards innovations like autonomous vehicles, or customer behavior prediction. For the biopharma industries specifically, AI represents an opportunity to avert the R&D productivity crisis with paradigm-shifting applications such as in-silico drug design, prediction of trial risks and big data analytics.
However, with every opportunity, there are risks and challenges, and in this blog, I will discuss how pharma needs to address the opacity of AI to ensure trust and credibility with all stakeholders.

Read More

Interview: Promoting precision medicine using data science 

January 23, 2018

 News Medical interviewed Dr. Rajat Mukherjee, Statistician, and Director of Data Science at Cytel to investigate the potential of data science in clinical development.

Read More

Removing 'Noise' from Biomedical Signals

September 7, 2017

By Munshi Imran Hossain, Software Affiliate at Cytel

Biomedical signals are electrical signals collected from the body. Some of the most common ones are the electrocardiogram (ECG) and the electroencephalogram (EEG). These signals are of great value because they can be used for diagnostic purposes. Importantly, most of them can be collected using non-invasive methods. These attributes, together with the tremendous recent advances in electronic and digital processing technology, have made biomedical signal data an important source of data used in medical diagnostics.

Read More